维普中文期刊产品整合服务
5篇 您的检索式:作者名="Sunbin Ling"
    题名 作者 年代 出处 被引量
1Metformin reverses multidrug resistance in human hepatocellular carcinomaBel?7402/5?fluorouracil cells显示文摘Sunbin Ling Yu Tian Haiquan Zhang Kaiqi Jia Tingting Feng Deguang Sun Zhenming Gao Fei Xu Zhaoyuan Hou Yan Li Liming Wang 2014Molecular Medicine Reports2014,,6:1
2Inflammation to cancer: The molecular biology in the pancreas (Review)显示文摘Sunbin Ling Tingting Feng Kaiqi Ji Yu Tian Yan Li 2014Oncology Letters2014,,:1
3Chinese Battery Industry显示文摘Sunbin W S Ling O U 200914(2): 1012009,14,2:1
4Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China(2021 edition)显示文摘Hepatocellular carcinoma(HCC)is the main cause of cancer-related deaths in adult men under the age of 60 years in China.^([1])Liver transplantation(LT)is generally recognized as one of the most effective therapeutic approaches for end-stage liver diseases.LT guidelines for HCC were firstly launched in 2014 and were updated in 2018.Recently,further updates are required to adapt to the new situation of LT in China and to continue advancing the recommendations.(Full version in Supplementary file,http://gffzz7970c142aa3c4dfahcccqk9n65npb6quq.ffgz.tsg.suse.edu.cn/CM9/B362).Jun Chen Tian Shen Jianhui Li Sunbin Ling Zhe Yang Guoying Wang Liying Sun Zhaoxu Yang Li Zhuang Jie Gao Wenyuan Guo Jie Li Shengjun Xu Qiang Wei Shusen Zheng Xiao Xu 2022Chinese Medical Journal2022,135,24:1
5RNA binding protein-based risk score model for prognosis prediction of patients with hepatocellular carcinoma显示文摘To the Editor:Liver cancer is estimated to be the sixth most lethal tumor,representing approximately 5.0%of all cancer-related deaths.[1]Mainly due to the high rate of infection with hepatitis B virus,liver cancer remains a serious health concern in China,severely limiting the extension of human life expectancy.In China,the number of new cases and deaths from liver cancer is projected to exceed 400,000 in 2022.[2]Hepatocellular carcinoma(HCC)is the major histological type of liver cancer and is a complex and highly heterogeneous disease.Due to the lack of early symptoms,patients with HCC are usually diagnosed at an advanced stage,thus losing the opportunity for surgical resection or liver transplantation.Tumor recurrence and metastasis are major bafflements that limit the efficiency of surgical therapeutics.It is urgent to explore the molecular mechanism of HCC to develop effective methods for early diagnosis and identify patients at high risk of tumor recurrence and metastasis.Shengjun Xu Ning Ding Sheng Zheng Jun Chen Yafeng Wan Sunbin Ling Xiao Xu 2022Chinese Medical Journal2022,135,23:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费